Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.79 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.72 |
| ▸ | FLT3 | P36888 | 1/20 | 0.71 |
| ▸ | CNR2 | P34972 | 1/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | MITF | O75030 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | CASP1 | P29466 | 1/20 | 0.68 |
| ▸ | CASP7 | P55210 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7902217 | 0.91 | MAPT (0.77) | MAPTCNR2KDM4ETP53ALDH1A1 | |
| SCHEMBL7892222 | 0.90 | MAPT (0.84) | MAPTCNR2KDM4ETP53ALDH1A1 | |
| SCHEMBL3917114 | 0.89 | MAPT (0.82) | MAPTFLT3CNR2KDM4ETP53 | |
| SCHEMBL3914054 | 0.89 | MAPT (0.82) | MAPTFLT3CNR2KDM4EMEN1 | |
| SCHEMBL15272081 | 0.89 | GRIN2C (0.79) | MAPTGRIN2CFLT3KDM4EMEN1 | |
| SCHEMBL21247199 | 0.88 | MAPT (1.00) | MAPTFLT3CNR2KDM4ETP53 | |
| SCHEMBL16562058 | 0.88 | MAPT (0.80) | MAPTCNR2THRBKDM4EMEN1 | |
| SCHEMBL3916162 | 0.88 | MAPT (0.80) | MAPTCNR2KDM4ETP53ALDH1A1 | |
| SCHEMBL7903456 | 0.87 | MAPT (0.79) | MAPTCNR2THRBKDM4ETP53 | |
| SCHEMBL8289604 | 0.87 | MAPT (0.78) | MAPTFLT3CNR2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3255083-B1 | PREFORM, FIBER-REINFORCED COMPOSITE MATERIAL, AND METHOD FOR MANUFACTURING FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES (JP) | 2021-09-15 | — | — | EP | disclosed |
| US-10792869-B2 | Preform, fiber-reinforced composite material, and method of manufacturing fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2020-10-06 | — | — | US | disclosed |
| US-10197933-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2019-02-05 | — | — | US | disclosed |
| US-10082742-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2018-09-25 | — | — | US | disclosed |
| US-20180264754-A1 | PREFORM, FIBER-REINFORCED COMPOSITE MATERIAL, AND METHOD OF MANUFACTURING FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2018-09-20 | — | — | US | disclosed |
| US-10054865-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2018-08-21 | — | — | US | disclosed |
| US-9989872-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2018-06-05 | — | — | US | disclosed |
| US-9989871-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2018-06-05 | — | — | US | disclosed |
| EP-2825917-B1 | TONER, METHOD FOR PRODUCING THE TONER, TWO-COMPONENT DEVELOPER, AND IMAGE FORMING APPARATUS | RICOH CO LTD (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-20180059562-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2018-03-01 | — | — | US | disclosed |
| US-20180059564-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2018-03-01 | — | — | US | disclosed |
| US-9904198-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-20170227871-A1 | IMAGE FORMING APPARATUS, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER | FUJI XEROX CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170184989-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20150051220-A1 | COMPOUNDS FOR USE IN THERAPY | GLUCOX BIOTECH AB (SE) | 2015-02-19 | — | — | US | disclosed |
| EP-2825165-A1 | THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY | Glucox Biotech AB (SE) | 2015-01-21 | — | — | EP | disclosed |
| EP-2825917-A1 | TONER, METHOD FOR PRODUCING THE TONER, TWO-COMPONENT DEVELOPER, AND IMAGE FORMING APPARATUS | Ricoh Company, Ltd. (JP) | 2015-01-21 | — | — | EP | disclosed |
| WO-2013135803-A1 | THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY | GLUCOX BIOTECH AB (SE) | 2013-09-19 | — | — | WO | disclosed |
| WO-2013137368-A1 | TONER, METHOD FOR PRODUCING THE TONER, TWO-COMPONENT DEVELOPER, AND IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2013-09-19 | — | — | WO | disclosed |
| WO-2005033102-A2 | THIOPHENE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF | AMPHORA DISCOVERY CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051220-A1 | COMPOUNDS FOR USE IN THERAPY | XDH, PNPO, OAT | MAPT 1102/4885GRIN2C 790/4885FLT3 2108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.